Table 3 B-cell subsets among subject... | American Society of Hematology

Table 3

B-cell subsets among subject groups

Group	CD19⁺,CD20⁺ cells,%	CD19⁺, CD20⁺ cells, %
Group	CD19⁺,CD20⁺ cells,%	κ⁺, λ⁻, %	κ⁺, CD27⁺,%	IgM⁺,CD27⁺, %	IgM⁺, IgD^low/−, %	CD21^low,CD27⁺, %	% CD5⁺
HCV Ab⁻, n = 16	14.74 ± 5.82	47.42 ± 11.30	17.23 ± 9.78	13.43 ± 7.59	8.21 ± 6.20	3.41 ± 2.29	22.18 ± 5.82
HCV⁻, Ab⁺, n = 10	13.75 ± 6.02	52.07 ± 4.98	17.33 ± 6.47	10.12 ± 4.66	5.61 ± 4.41	3.47 ± 3.41	13.75 ± 6.02
HCV⁺ clonal, n = 11	18.55 ± 6.73	65.23 ± 20.84*	42.40 ± 22.16†	35.90 ± 25.53*	23.85 ± 19.85	20.94 ± 17.64*	18.55 ± 6.73
HCV⁺ polyclonal, n = 14	20.14 ± 8.17	51.72 ± 6.53	19.22 ± 15.33	15.61 ± 13.03	9.73 ± 9.92	4.86 ± 2.80	20.14 ± 8.17

Group	CD19⁺,CD20⁺ cells,%	CD19⁺, CD20⁺ cells, %
Group	CD19⁺,CD20⁺ cells,%	κ⁺, λ⁻, %	κ⁺, CD27⁺,%	IgM⁺,CD27⁺, %	IgM⁺, IgD^low/−, %	CD21^low,CD27⁺, %	% CD5⁺
HCV Ab⁻, n = 16	14.74 ± 5.82	47.42 ± 11.30	17.23 ± 9.78	13.43 ± 7.59	8.21 ± 6.20	3.41 ± 2.29	22.18 ± 5.82
HCV⁻, Ab⁺, n = 10	13.75 ± 6.02	52.07 ± 4.98	17.33 ± 6.47	10.12 ± 4.66	5.61 ± 4.41	3.47 ± 3.41	13.75 ± 6.02
HCV⁺ clonal, n = 11	18.55 ± 6.73	65.23 ± 20.84*	42.40 ± 22.16†	35.90 ± 25.53*	23.85 ± 19.85	20.94 ± 17.64*	18.55 ± 6.73
HCV⁺ polyclonal, n = 14	20.14 ± 8.17	51.72 ± 6.53	19.22 ± 15.33	15.61 ± 13.03	9.73 ± 9.92	4.86 ± 2.80	20.14 ± 8.17

Values are means (± SD).

P < .05, Dunn multiple comparison test.

P < .01, Dunn multiple comparison test.